Annotated Bibliography

Ambruso, D. R., C. Knall, A. N. Abell, J. Panepinto, A. Kurkchubasche, G. Thurman, C. Gonzalez-Aller, et al. 2000. “Human Neutrophil Immunodeficiency Syndrome Is Associated with an Inhibitory Rac2 Mutation.” Proceedings of the National Academy of Sciences 97 (9): 4654–59. doi:10.1073/pnas.080074897.

Babior, B M. 1984. “The Respiratory Burst of Phagocytes.” Journal of Clinical Investigation 73 (3): 599–601. doi:10.1172/JCI111249.

Babior, B. M. 1999. “NADPH Oxidase: An Update.” Blood 93 (5): 1464–76.

Baehner, R. L., and D. G. Nathan. 1967. “Leukocyte Oxidase: Defective Activity in Chronic Granulomatous Disease.” Science 155 (3764): 835–36. doi:10.1126/science.155.3764.835.

Bagaitkar, Juhi, Nancy K. Pech, Stoyan Ivanov, Anthony Austin, Melody Yue Zeng, Sabine Pallat, Guangming Huang, Gwendalyn J. Randolph, and Mary C. Dinauer. 2015. “NADPH Oxidase Controls Neutrophilic Response to Sterile Inflammation in Mice by Regulating the IL-1α/G-CSF Axis.” Blood 126 (25): 2724–33. doi:10.1182/blood-2015-05-644773.

Bionda, Clara, Xing Jun Li, Robin van Bruggen, Michel Eppink, Dirk Roos, Françoise Morel, and Marie-José Stasia. 2004. “Functional Analysis of Two-Amino Acid Substitutions in gp91 Phox in a Patient with X-Linked Flavocytochrome b558-Positive Chronic Granulomatous Disease by Means of Transgenic PLB-985 Cells.” Human Genetics 115 (5): 418–27. doi:10.1007/s00439-004-1173-z.

Borregaard, N., J. M. Heiple, E. R. Simons, and R. A. Clark. 1983. “Subcellular Localization of the B-Cytochrome Component of the Human Neutrophil Microbicidal Oxidase: Translocation during Activation.” The Journal of Cell Biology 97 (1): 52–61.

Bridges, Robert A. 1959. “A Fatal Granulomatous Disease of Childhood: The Clinical, Pathological, and Laboratory Features of a New Syndrome.” A.M.A. Journal of Diseases of Children 97 (4): 387. doi:10.1001/archpedi.1959.02070010389004.

Chiriaco, Maria, Irene Salfa, Gigliola Di Matteo, Paolo Rossi, and Andrea Finocchi. 2015. “Chronic Granulomatous Disease: Clinical, Molecular and Therapeutic Aspects.” Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology, December. doi:10.1111/pai.12527.

Curnutte, John T., Dana M. Whitten, and Bernard M. Babior. 1974. “Defective Superoxide Production by Granulocytes from Patients with Chronic Granulomatous Disease.” New England Journal of Medicine 290 (11): 593–97. doi:10.1056/NEJM197403142901104.

El-Benna, Jamel, Pham My-Chan Dang, and Marie-Anne Gougerot-Pocidalo. 2008. “Priming of the Neutrophil NADPH Oxidase Activation: Role of p47phox Phosphorylation and NOX2 Mobilization to the Plasma Membrane.” Seminars in Immunopathology 30 (3): 279–89. doi:10.1007/s00281-008-0118-3.

Epstein, W. L., and K. Fukuyama. 1989. “Mechanisms of Granulomatous Inflammation.” Immunology Series 46: 687–721.

Falcone, E. Liana, and Steven M. Holland. 2012. “Invasive Fungal Infection in Chronic Granulomatous Disease: Insights into Pathogenesis and Management.” Current Opinion in Infectious Diseases 25 (6): 658–69. doi:10.1097/QCO.0b013e328358b0a4.

Fernandez-Boyanapalli, Ruby F., S. Courtney Frasch, Stacey M. Thomas, Kenneth C. Malcolm, Michael Nicks, Ronald J. Harbeck, Claudia V. Jakubzick, et al. 2015. “Pioglitazone Restores Phagocyte Mitochondrial Oxidants and Bactericidal Capacity in Chronic Granulomatous Disease.” The Journal of Allergy and Clinical Immunology 135 (2): 517–27.e12. doi:10.1016/j.jaci.2014.10.034.

Fernandez-Boyanapalli, Ruby, S. Courtney Frasch, David W. H. Riches, R. William Vandivier, Peter M. Henson, and Donna L. Bratton. 2010. “PPARγ Activation Normalizes Resolution of Acute Sterile Inflammation in Murine Chronic Granulomatous Disease.” Blood 116 (22): 4512–22. doi:10.1182/blood-2010-02-272005.

Flynn, Rowan, Alexander Grundmann, Peter Renz, Walther Hänseler, William S. James, Sally A. Cowley, and Michael D. Moore. 2015. “CRISPR-Mediated Genotypic and Phenotypic Correction of a Chronic Granulomatous Disease Mutation in Human iPS Cells.” Experimental Hematology 43 (10): 838–48.e3. doi:10.1016/j.exphem.2015.06.002.

Furtmüller, Paul G., Christian Obinger, Yuchiong Hsuanyu, and H. Brian Dunford. 2000. “Mechanism of Reaction of Myeloperoxidase with Hydrogen Peroxide and Chloride Ion: Reaction of Myeloperoxidase MPO-I with Chloride.” European Journal of Biochemistry 267 (19): 5858–64. doi:10.1046/j.1432-1327.2000.01491.x.

Ghosh, Sankar, and Michael Karin. 2002. “Missing Pieces in the NF-κB Puzzle.” Cell 109 (2): S81–96. doi:10.1016/S0092-8674(02)00703-1.

Grizot, S., F. Fieschi, M. C. Dagher, and E. Pebay-Peyroula. 2001. “The Active N-Terminal Region of p67phox. Structure at 1.8 A Resolution and Biochemical Characterizations of the A128V Mutant Implicated in Chronic Granulomatous Disease.” The Journal of Biological Chemistry 276 (24): 21627–31. doi:10.1074/jbc.M100893200.

Han, C. H., Y. Nisimoto, S. H. Lee, E. T. Kim, and J. D. Lambeth. 2001. “Characterization of the Flavoprotein Domain of gp91phox Which Has NADPH Diaphorase Activity.” Journal of Biochemistry 129 (4): 513–20.

Han, W., H. Li, J. Cai, L. A. Gleaves, V. V. Polosukhin, B. H. Segal, F. E. Yull, and T. S. Blackwell. 2013. “NADPH Oxidase Limits Lipopolysaccharide-Induced Lung Inflammation and Injury in Mice through Reduction-Oxidation Regulation of NF- B Activity.” The Journal of Immunology 190 (9): 4786–94. doi:10.4049/jimmunol.1201809.

Holmes, Beulah, PaulG. Quie, DorothyB. Windhorst, and RobertA. Good. 1966. “FATAL GRANULOMATOUS DISEASE OF CHILDHOOD.” The Lancet 287 (7449): 1225–28. doi:10.1016/S0140-6736(66)90238-8.

Iwata, M., H. Nunoi, H. Yamazaki, T. Nakano, H. Niwa, S. Tsuruta, S. Ohga, S. Ohmi, S. Kanegasaki, and I. Matsuda. 1994. “Homologous Dinucleotide (GT or TG) Deletion in Japanese Patients with Chronic Granulomatous Disease with p47-Phox Deficiency.” Biochemical and Biophysical Research Communications 199 (3): 1372–77. doi:10.1006/bbrc.1994.1382.

Jakobsen, M. A., T. L. Katzenstein, N. H. Valerius, D. Roos, N. Fisker, T. H. Mogensen, P. Ø Jensen, and T. Barington. 2012. “Genetical Analysis of All Danish Patients Diagnosed with Chronic Granulomatous Disease.” Scandinavian Journal of Immunology 76 (5): 505–11. doi:10.1111/j.1365-3083.2012.02771.x.

Ko, Sun Hi, Jung Woo Rhim, Kyung Sue Shin, Youn Soo Hahn, So Young Lee, and Joong Gon Kim. 2014. “Genetic Analysis of CYBB Gene in 26 Korean Families with X-Linked Chronic Granulomatous Disease.” Immunological Investigations 43 (6): 585–94. doi:10.3109/08820139.2013.825270.

Leusen, J. H. 1994. “156Pro–>Gln Substitution in the Light Chain of Cytochrome b558 of the Human NADPH Oxidase (p22-Phox) Leads to Defective Translocation of the Cytosolic Proteins p47-Phox and p67-Phox.” Journal of Experimental Medicine 180 (6): 2329–34. doi:10.1084/jem.180.6.2329.

Leusen, J. H. 1996. “Disturbed Interaction of p21-Rac with Mutated p67-Phox Causes Chronic Granulomatous Disease.” Journal of Experimental Medicine 184 (4): 1243–49. doi:10.1084/jem.184.4.1243.

Marciano, Beatriz E., Sergio D. Rosenzweig, David E. Kleiner, Victoria L. Anderson, Dirk N. Darnell, Sandra Anaya-O’Brien, Dianne M. Hilligoss, Harry L. Malech, John I. Gallin, and Steven M. Holland. 2004. “Gastrointestinal Involvement in Chronic Granulomatous Disease.” Pediatrics 114 (2): 462–68.

Margolis, D. M., D. A. Melnick, D. W. Alling, and J. I. Gallin. 1990. “Trimethoprim-Sulfamethoxazole Prophylaxis in the Management of Chronic Granulomatous Disease.” The Journal of Infectious Diseases 162 (3): 723–26.

Martin, Laura. 2015. “Nitroblue Tetrazolium Blood Test.” MedlinePlus. U.S. National Library of Medicine.

Martire, Baldassarre, Roberto Rondelli, Annarosa Soresina, Claudio Pignata, Teresa Broccoletti, Andrea Finocchi, Paolo Rossi, et al. 2008. “Clinical Features, Long-Term Follow-up and Outcome of a Large Cohort of Patients with Chronic Granulomatous Disease: An Italian Multicenter Study.” Clinical Immunology (Orlando, Fla.) 126 (2): 155–64. doi:10.1016/j.clim.2007.09.008.

Ohye, H., and M. Sugawara. 2010. “Dual Oxidase, Hydrogen Peroxide and Thyroid Diseases.” Experimental Biology and Medicine 235 (4): 424–33. doi:10.1258/ebm.2009.009241.

Parta, Mark, Dianne Hilligoss, Corin Kelly, Nana Kwatemaa, Narda Theobald, Harry Malech, and Elizabeth M. Kang. 2015. “Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in a Patient with Chronic Granulomatous Disease and Active Infection: A First Report.” Journal of Clinical Immunology 35 (7): 675–80. doi:10.1007/s10875-015-0204-y.

Quie, P. G., J. G. White, B. Holmes, and R. A. Good. 1967. “In Vitro Bactericidal Capacity of Human Polymorphonuclear Leukocytes: Diminished Activity in Chronic Granulomatous Disease of Childhood *.” Journal of Clinical Investigation 46 (4): 668–79. doi:10.1172/JCI105568.

Rae, Julie, Peter E. Newburger, Mary C. Dinauer, Deborah Noack, Penelope J. Hopkins, Ryoko Kuruto, and John T. Curnutte. 1998. “X-Linked Chronic Granulomatous Disease: Mutations in the CYBB Gene Encoding the gp91-Phox Component of Respiratory-Burst Oxidase.” The American Journal of Human Genetics 62 (6): 1320–31. doi:10.1086/301874.

Segal, Anthony W., and Owen T. G. Jones. 1978. “Novel Cytochrome B System in Phagocytic Vacuoles of Human Granulocytes.” Nature 276 (5687): 515–17. doi:10.1038/276515a0.

Segal, Brahm H., Wei Han, Jennifer J. Bushey, Myungsoo Joo, Zahida Bhatti, Joy Feminella, Carly G. Dennis, et al. 2010. “NADPH Oxidase Limits Innate Immune Responses in the Lungs in Mice.” Edited by Amit Gaggar. PLoS ONE 5 (3): e9631. doi:10.1371/journal.pone.0009631.

Sheppard, Forest R., Marguerite R. Kelher, Ernest E. Moore, Nathan J. D. McLaughlin, Anirban Banerjee, and Christopher C. Silliman. 2005. “Structural Organization of the Neutrophil NADPH Oxidase: Phosphorylation and Translocation during Priming and Activation.” Journal of Leukocyte Biology 78 (5): 1025–42. doi:10.1189/jlb.0804442.

Song, Eunkyung, Gayatri Bala Jaishankar, Hana Saleh, Warit Jithpratuck, Ryan Sahni, and Guha Krishnaswamy. 2011. “Chronic Granulomatous Disease: A Review of the Infectious and Inflammatory Complications.” Clinical and Molecular Allergy: CMA 9 (1): 10. doi:10.1186/1476-7961-9-10.

Stasia, Marie José, Jean-Paul Brion, Jean Boutonnat, and Françoise Morel. 2003. “Severe Clinical Forms of Cytochrome B-Negative Chronic Granulomatous Disease (X91-) in 3 Brothers with a Point Mutation in the Promoter Region of CYBB.” The Journal of Infectious Diseases 188 (10): 1593–1604. doi:10.1086/379035.

Takeya, Ryu, and Hideki Sumimoto. 2003. “Molecular Mechanism for Activation of Superoxide-Producing NADPH Oxidases.” Molecules and Cells 16 (3): 271–77.

Ueyama, T., J. Nakakita, T. Nakamura, T. Kobayashi, T. Kobayashi, J. Son, M. Sakuma, H. Sakaguchi, T. L. Leto, and N. Saito. 2011. “Cooperation of p40phox with p47phox for Nox2-Based NADPH Oxidase Activation during Fc Receptor (Fc R)-Mediated Phagocytosis: MECHANISM FOR ACQUISITION OF p40phox PHOSPHATIDYLINOSITOL 3-PHOSPHATE (PI(3)P) BINDING.” Journal of Biological Chemistry 286 (47): 40693–705. doi:10.1074/jbc.M111.237289.

Vignais, P. V. 2002. “The Superoxide-Generating NADPH Oxidase: Structural Aspects and Activation Mechanism.” Cellular and Molecular Life Sciences: CMLS 59 (9): 1428–59.

Weisser, Maren, Uta M. Demel, Stefan Stein, Linping Chen-Wichmann, Fabien Touzot, Giorgia Santilli, Stefanie Sujer, et al. 2016. “Hyperinflammation in Patients with Chronic Granulomatous Disease Leads to Impairment of Hematopoietic Stem Cell Functions.” The Journal of Allergy and Clinical Immunology, February. doi:10.1016/j.jaci.2015.11.028.

Wientjes, F. B., J. J. Hsuan, N. F. Totty, and A. W. Segal. 1993. “p40phox, a Third Cytosolic Component of the Activation Complex of the NADPH Oxidase to Contain Src Homology 3 Domains.” The Biochemical Journal 296 ( Pt 3) (December): 557–61.

Yepes, Edward, Rubén E. Varela-M, Julio López-Abán, Jose Rojas-Caraballo, Antonio Muro, and Faustino Mollinedo. 2015. “Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel.” Edited by Michael H. Hsieh. PLOS Neglected Tropical Diseases 9 (7): e0003893. doi:10.1371/journal.pntd.0003893.

Zhu, Yanmin, Christophe C. Marchal, Amy-Jo Casbon, Natalie Stull, Katharina von Löhneysen, Ulla G. Knaus, Algirdas J. Jesaitis, Sally McCormick, William M. Nauseef, and Mary C. Dinauer. 2006. “Deletion Mutagenesis of p22phox Subunit of Flavocytochrome b558: Identification of Regions Critical for gp91phox Maturation and NADPH Oxidase Activity.” The Journal of Biological Chemistry 281 (41): 30336–46. doi:10.1074/jbc.M607191200.


Last updated 5/6/16